UM/Israel symposium elevates scientific discovery
Medical scientists from Israel’s premier universities will join University of Michigan colleagues this week for a 5th year of partnership, collaboration and synergy.
Attendees will explore the convergence of biomedicine and bioengineering during the D. Dan and Betty Kahn Michigan-Israel Partnership for Research and Education Scientific Symposium, held May 14-16, in Ann Arbor.
The partnership includes the University of Michigan’s Frankel Cardiovascular Center and the Life Sciences Institute with ties to Technion-Israel Institute of Technology and Weizmann Institute of Science.
The initiative pairs U-M medical school and life sciences faculty and researchers with peers in Israel to conduct joint scientific investigations. The goal is to advance research in areas relevant to human health and increase international understanding and cooperation.
Keynote speakers will present the latest research on topic ranging from engineering molecules, cells and tissues to exploring the impact of biomedical and bioengineering on patient’s lives. Additional topics include new insights into the biology of stem cells and technology advances leading to scientific discoveries.
On the opening day, keynote speakers include Shuichi Takayama, Ph.D., professor and associate chair of technology transfer in the U-M Department of Biomedical Engineering at the University of Michigan and Paul Cederna, M.D., section head of plastic surgery and professor in the U-M Department of Biomedical Engineering. Poster awards will be presented Monday.
The attendees span the fields of life science, medical science and realms such as imaging, physics and nanotechnology as they seek to collaborate on new discovery, therapies and tools for treating disease.
The goal is to advance research in areas relevant to human health and increase international understanding and cooperation.